With the number of MS components increasing, serum SHBG levels decreased, with the linear trend statically significant in non-NAFLD group (P for linear trend <0.001, one-way ANOVA), but not in NAFLD group (P for linear trend = 0.059, one-way ANOVA). This evidence concerns the gene SHBG and metabolic dysfunction-associated steatotic liver disease.